HTG Molecular Diagnostics, Inc. HTGMQ
OTC PK
| 03/31/2023 | 12/31/2022 | 09/30/2022 | 06/30/2022 | 03/31/2022 | |
|---|---|---|---|---|---|
| Net Income | -7.22% | -25.95% | -36.01% | -- | -- |
| Total Depreciation and Amortization | -31.19% | -18.61% | -26.86% | -- | -- |
| Total Amortization of Deferred Charges | -21.08% | -12.21% | -5.37% | -- | -- |
| Total Other Non-Cash Items | 1,404.65% | 435.98% | 179.87% | -- | -- |
| Change in Net Operating Assets | 75.75% | 85.54% | 84.59% | -- | -- |
| Cash from Operations | 6.98% | -11.50% | -18.63% | -- | -- |
| Capital Expenditure | 96.23% | 96.42% | 87.74% | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 64.64% | 304.95% | 432.98% | -- | -- |
| Cash from Investing | 130.48% | 286.36% | 384.00% | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -255.89% | -915.96% | -782.63% | -- | -- |
| Issuance of Common Stock | -25.90% | 42.67% | -42.20% | -- | -- |
| Repurchase of Common Stock | -5,301.96% | -16,836.36% | -14,615.79% | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 44.13% | -4.32% | 26.62% | -- | -- |
| Cash from Financing | -81.67% | -17.19% | -92.87% | -- | -- |
| Foreign Exchange rate Adjustments | 112.00% | 60.87% | -1,140.00% | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -62.19% | 120.40% | 18.92% | -- | -- |